Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer

Figure 1 Receiver operating characteristic curve analysis of the lymphocyte to monocyte ratio in patients with unresectable metastatic colorectal cancer. Area under the curve = 0.703, 95%CI: 0.594-0.812, P = 0.001, positive predictive value = 80.65%, negative predictive value = 59.65%.

Figure 2 Overall survival. A: According to the pre-treatment LMR. The overall survival rate was significantly worse in the low pre-treatment LMR group than in the high pre-treatment LMR group (P = 0.0011); B: According to the combination of the pre-treatment and post-treatment LMR values. The patients in group C exhibited a worse prognosis than those in groups A and B; C: According to the combination of the pre-treatment and post-treatment neutrophil to lymphocyte ratio values. There was no significant difference between groups E and F. LMR: Lymphocyte to monocyte ratio.